Crohn's disease pharmascape cv
Which difference should we target? Alberto Sobrero Ospedale San Martino IRCCS Genova, Italy.
Raising the bar of efficacy in cancer therapeutics Alberto Sobrero Ospedale San Martino Genova, Italy.
Post Conference Update: Highlights from the American Association of the Study of Liver Diseases MARK SULKOWSKI, MD Associate Professor of Medicine Johns.
Which difference should we target?
Global Glaucoma Treatment Market - Trends And Opportunities: 2015 Edition - New Research by Daedal Research
Regional Update 2 Financial Report 3 Governance Report 4.
Edited by Morris Sherman MD BCh PhD FRCP(C) Associate Professor of Medicine
History of Alpha Interferon Therapy of Chronic Hepatitis C Paris Hepatitis Conference: 2012 Jay H. Hoofnagle, M.D. Director, Liver Disease Research Branch.
1 Key note session at Bangalore India BIO on Actualizing Potential of Clinical Trials June 4 th 2010 D A Prasanna Founder & Vice Chairman Ecron Acunova.
Regional Update
